Cervicogenic Headache Clinical Trial
Official title:
Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option in Cervicogenic Headache? A Randomized Controlled Clinical Trial.
This study will highlight and validate chiropractic spinal manipulative therapy (CSMT) for
cervicogenic headache (CEH). If the method proves to be effective, it will provide a new
non-pharmacological treatment option for CEH. This is especially important since
pharmacological management has minor effect in CEH, and alternative treatment options are
warranted. The applied methodology of the study will aim towards the highest possible
research standards. This international study is a collaboration between Akershus University
Hospital, Innlandet Hospital and University of Oslo (UiO), Norway and Macquarie University,
Australia. The multidisciplinary professional backgrounds are physiotherapy, chiropractic and
medicine. By increasing the methodological quality of the investigators research to a very
high level, the investigators see the method to work as a guide to increase the quality of
chiropractic research in the future, as previous randomized clinical trials (RCTs) of CEH
used methodology showing room for improvement.
Study hypothesis:
CSMT using the Gonstead method reduces days with CEH by at least 25% as compared to placebo
(sham manipulation, i.e. broad non-specific contact, non-directional, low velocity and low
amplitude) and no intervention (control group).
Cervicogenic headache (CEH) is a symptomatic headache characterized by chronic unilateral
headache and symptoms and signs of neck involvement. CEH is often worsened by neck movement,
sustained awkward head position, external pressure over the upper cervical or occipital
region on the symptomatic side. Abolition of the headache following diagnostic anesthetic
blocks of cervical structures or local factors in neck give evidence that the pain is
attributed to a neck disorder or lesion. The prevalence of CEH is 0.2% in the general
population of Akershus County, i.e. 9,000 Norwegians have CEH. However, the prevalence varies
between 0.4-4.1% in studies applying less rigorous diagnostic criteria. The efficacy of
pharmacological management in CEH is poor. Patients suffering from CEH are commonly treated
with CSMT, but the methodology has one or more shortcomings in all studies. In addition, the
RCTs mostly included participant with infrequent CEH and did not follow the recommended
clinical guidelines by the International Headache Society (IHS) of intervention of at least
three months. An analysis of the literature as well as a recent pilot study suggests that
CSMT has an effect on headache intensity and duration, and medication intake. However, a
randomized controlled clinical trial with high methodological quality on CEH still remains to
be conducted.
The RCT is single blinded, placebo-controlled trial of CSMT using the Gonstead method vs.
sham manipulation and control group. If the treatment shows to be effective, the participants
whom receive sham manipulation or control will be offered true intervention after the
follow-up period and free of charge. This study will follow the recommendations set by the
clinical trial guidelines from the IHS, while the methodological quality control will in
general follow previous suggested criteria and the CONSORT statements.
Patients will be recruited through Akershus University Hospital and Innlandet Hospital,
Norway as well as through media advertising in Akershus and Oslo County. The diagnose is set
by a chiropractor and a neurologist with experience in headache.
The clinical trials consist of three stages: Run-in, intervention (treatment) and follow-up.
One month of base line data collection where participants will fill-in a diagnostic headache
diary. Baseline demographics and clinical characteristics will be presented in tables with
mean and standard deviation (SD) for each group.
The participants will be randomized by drawing prepared sealed lots. Each lot includes three
different interventions, i.e active treatment, sham manipulation and control group. The first
three participants will draw from the same lot until all three interventions are used. The
next lot with three interventions is then followed by the next three participants.
The RCTs will be conducted by an experienced chiropractor. Active treatment consists of CSMT
using the Gonstead method. A specific contact, high velocity, low amplitude, short lever,
with no recoil post adjustment directed to spinal biomechanical dysfunction diagnosed by
standard chiropractic tests.
Follow-up at 3, 6 and 12 months post-treatment. During this period participants continue to
fill in a diagnostic headache diary. The control group will also be included in this phase of
the study.
The data will be analyzed with SPSS using standard statistical techniques.
The investigators based our calculation of sample size on migraine days from recent group
comparison studies of topiramate (38). The investigators calculated that a sample size of 16
patients was required to detect a difference in mean reduction in monthly headache days of
2.5 with 80% power, with p=0.05 as level of significance, and assuming a common SD of 2.5 for
active treatment and broad-based treatment groups.
Insurance is through "The Norwegian System of Compensation to Patients" (NPE) which is an
independent national body, set up to process compensation claims from patients who have
suffered an injury as a result of treatment under the Norwegian health service.
The Regional Committee for Medical Research Ethics (REK) in Norway and Norwegian Social
Science Data Services approved the full PhD research protocol. The declaration of Helsinski
is followed.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05545423 -
Effect of Instrument-Assisted Soft Tissue Mobilization on Proprioception and Disability in Patients With Cervicogenic Headache
|
N/A | |
Not yet recruiting |
NCT05289414 -
Radiofrquency Targeting Mid Cervical Medial Branches vs GON in Cervicogenic Headache
|
Phase 2/Phase 3 | |
Recruiting |
NCT05617365 -
Treating Chronic Cervicogenic Head and Neck Pain
|
Phase 1/Phase 2 | |
Recruiting |
NCT05491915 -
The MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain
|
N/A | |
Active, not recruiting |
NCT02908984 -
Specific Neck Rehabilitation for Unilateral Headache and Neck Pain, and Structural and Functional Changes in the Brain
|
N/A | |
Completed |
NCT01790074 -
Trigger Point Therapy in Cervicogenic Headache
|
N/A | |
Terminated |
NCT03730896 -
Effectiveness of Dry Needling of the Sternocleidomastoid in Patients With Cervicogenic Headaches
|
N/A | |
Completed |
NCT05582616 -
The Safety and Feasibility of tDCS Combined With Conservative Treatment for Cervicogenic Headaches
|
N/A | |
Recruiting |
NCT06459726 -
Effects of Shi Style Cervical Mobilization Versus SNAGS in Patients With Cervicogenic Headache
|
N/A | |
Completed |
NCT04521218 -
Thrust Joint Manipulation and Reverse SNAGS (Sustained Natural Apophyseal Glides) in Cervicogenic Headache
|
N/A | |
Completed |
NCT00184197 -
Botulinum Toxin Injection in Neck Muscles in Cervicogenic Headache
|
Phase 2 | |
Completed |
NCT04625387 -
Dry Needle In Management of Cervicogenic Headache
|
N/A | |
Completed |
NCT05865808 -
Effects of Sustained Natural Appophyseal Glide Versus Rocababo 6x6 Program in Subjects With Cervicogenic Headache.
|
N/A | |
Completed |
NCT05827185 -
Effects of Workstation Ergonomics and Physiotherapy in Cervicogenic Headache.
|
Phase 2 | |
Completed |
NCT03919630 -
Mobilization Versus Manipulation for the Treatment of Cervicogenic Headaches
|
N/A | |
Completed |
NCT04454541 -
Efficacy of Ultrasound-Guided Multifidus Cervicis Plan Block Vs Greater Occipital Nerve Block for Cervicogenic Headache
|
N/A | |
Completed |
NCT04242290 -
Cervicospinal Posture and Pain in Cervicogenic Headache
|
||
Completed |
NCT05754931 -
Deep Neck Flexors Training Versus Muscle Energy Technique on Cervicogenic Headache
|
N/A | |
Completed |
NCT05849545 -
Effects of Garston Tool and Neuromuscular Reeducation in Cervical Headache
|
N/A | |
Recruiting |
NCT05312645 -
Diclofenac Gel in the Treatment of Cervicogenic Headache
|
Phase 3 |